Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients withde novodiffuse large B cell lymphoma-Reference-Cited by-同舟云学术

Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients withde novodiffuse large B cell lymphoma

Published:2015-07-29 Issue:3 Volume:173 Page:487-491
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Eyre Toby A.¹,Salisbury Richard¹,Eyre David W.²,Watson Caroline¹,Collins Graham P.¹,Hatton Chris S.¹

Affiliation:

1. Department of Haematology; Oxford University Hospitals NHS Trust; Oxford UK

2. Nuffield Department of Medicine; University of Oxford; Oxford UK

Funder

Julian Starmer-Smith Lymphoma Fund

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13619/fullpdf

Reference10 articles.

1. Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma;Carson;Journal of Geriatric Oncology,2015

2. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;New England Journal of Medicine,2002

3. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma;Habermann;Journal of Clinical Oncology,2006

4. Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma;Hirakawa;Annals of Hematology,2010

5. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001;Morton;Blood,2006

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of bortezomib and venetoclax targets the pro-survival function of LMP-1 and EBNA-3C of Epstein-Barr virus in post-transplant lymphoproliferative disorder;2024-05-13

2. Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study;The Korean Journal of Internal Medicine;2024-05-01

3. The management of newly diagnosed large B‐cell lymphoma: A British Society for Haematology Guideline;British Journal of Haematology;2024-01-21

4. Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma;Journal of Clinical and Experimental Hematopathology;2023-12-26

5. Prognostic Impact of Prephase Treatment Prior to First-Line Treatment in DLBCL: A Population-Based Registry Study;European Journal of Cancer Care;2023-09-25